User menu

Identification of positively charged residues contributing to the stability of plasminogen activator inhibitor 1

Bibliographic reference Gils, A ; Lu, J. ; Aertgeerts, K ; Knockaert, I ; Declerck, PJ. Identification of positively charged residues contributing to the stability of plasminogen activator inhibitor 1. In: FEBS Letters, Vol. 415, no. 2, p. 192-195 (1997)
Permanent URL
  1. Review, 10.1515/bchm3.1996.377.1.1
  2. Wright H. Tonie, The structural puzzle of how serpin serine proteinase inhibitors work, 10.1002/bies.950180607
  3. Laskowski M, Kato I, Protein Inhibitors of Proteinases, 10.1146/
  4. Lindahl T L, Ohlsson P I, Wiman B, The mechanism of the reaction between human plasminogen-activator inhibitor 1 and tissue plasminogen activator, 10.1042/bj2650109
  5. Mottonen James, Strand Arne, Symersky Jindrich, Sweet Robert M., Danley Dennis E., Geoghegan Kieran F., Gerard Robert D., Goldsmith Elizabeth J., Structural basis of latency in plasminogen activator inhibitor-1, 10.1038/355270a0
  6. Hekman, J. Biol. Chem., 260, 11581 (1985)
  7. Declerck, J. Biol. Chem., 267, 11693 (1992)
  8. URANO Tetsumei, STRANDBERG Leif, JOHANSSON Lennart B.-A., NY Tor, A substrate-like form of plasminogen-activator-inhibitor type 1. Conversions between different forms by sodium dodecyl sulphate, 10.1111/j.1432-1033.1992.tb17372.x
  9. Munch Mette, Heegaard Christian W., Andreasen Peter A., Interconversions between active, inert and substrate forms of denatured/refolded type-1 plasminogen activator inhibitor, 10.1016/0167-4838(93)90059-z
  10. Seetharam Ramnath, Dwivedi Anil M., Duke Jodie L., Hayman Alan C., Walton Harry L., Huckins Nancy R., Kamerkar Shubi M., Corman Jeanne I., Woodeshick Robert W., Purification and characterization of active and latent forms of recombinant plasminogen activator inhibitor 1 produced in Escherichia coli, 10.1021/bi00156a004
  11. Vaughan Douglas E., Declerck Paul J., Reilly Thomas M., Park Kyusung, Collen Désiré, Fasman Gerald D., Dynamic structural and functional relationships in recombinant plasminogen activator inhibitor-1 (rPAI-1), 10.1016/0167-4838(93)90008-f
  12. Sancho Elena, Declerck Paul J., Price Nicholas C., Kelly Sharon M., Booth Nuala A., Conformational Studies on Plasminogen Activator Inhibitor (PAI-1) in Active, Latent, Substrate, and Cleaved Forms, 10.1021/bi00003a042
  13. Schulze Andreas J., Quarzago Daniela, Andreasen Peter A., A Spectroscopic Study of the Structures of Latent, Active and Reactive-Center-Cleaved Type-1 Plasminogen-Activator Inhibitor, 10.1111/j.1432-1033.1996.0550h.x
  14. Gils Ann, Knockaert Isabelle, Declerck Paul J., Substrate Behavior of Plasminogen Activator Inhibitor-1 Is Not Associated with a Lack of Insertion of the Reactive Site Loop†, 10.1021/bi960079d
  15. Aertgeerts Kathleen, De Bondt Hendrik L., De Ranter Camiel J., Declerck Paul J., Mechanisms contributing to the conformational and functional flexibility of plasminogen activator inhibitor-1, 10.1038/nsb1095-891
  16. Engh, Behring Inst. Mitt., 93, 41 (1994)
  17. Audenaert, J. Biol. Chem., 269, 19559 (1994)
  18. Stanssens Patrick, Opsomer Chris, McKeown Yvonne M., Kramer Wilfried, Zabeau Marc, Fritz Hans-Joachim, Efficient oligonucleotide-directed construction of mutations in expression vectors by the gapped duplex DNA method using alternating selectable markers, 10.1093/nar/17.12.4441
  19. Declerck, Fibrinolysis (Suppl. 2), 6, 90 (1992)
  20. Verheijen, Thromb. Haemost., 51, 392 (1984)
  21. Sancho Elena, Tonge David W., Hockney Robert C., Booth Nuala A., Purification and Characterization of Active and Stable Recombinant Plasminogen-Activator Inhibitor Accumulated at High Levels in Escherichia coli, 10.1111/j.1432-1033.1994.tb20003.x
  22. Declerck, Fibrinolysis (Suppl. 2), 4, 132 (1990)
  23. Carrell Robin W., Evans Dyfed Ll., Stein Penelope E., Mobile reactive centre of serpins and the control of thrombosis, 10.1038/353576a0
  24. Lomas David A., Elliott Peter R., Chang Wun-Shaing W., Wardell Mark R., Carrell Robin W., Preparation and Characterization of Latent α1-Antitrypsin, 10.1074/jbc.270.10.5282
  25. Lawrence D. A., Olson S. T., Palaniappan S., Ginsburg D., Engineering Plasminogen Activator Inhibitor 1 Mutants with Increased Functional Stability, 10.1021/bi00178a022
  26. Berkenpas, EMBO J., 14, 2969 (1995)
  27. Tucker H. Michael, Mottonen James, Goldsmith Elizabeth J., Gerard Robert D., Engineering of plasminogen activator inhibitor-1 to reduce the rate of latency transition, 10.1038/nsb0695-442
  28. Bijnens, Thromb. Haemost., 77, 350 (1997)